MediPal Holdings Corporation (MAHLY)

Market Cap	4.14B +19.8%
Revenue (ttm)	24.75B +3.9%
Net Income	276.62M +7.0%
EPS	1.34 +8.4%
Shares Out	n/a
PE Ratio	15.03
Forward PE	n/a
Dividend	0.56 (2.76%)
Ex-Dividend Date	Mar 30, 2027

Volume	122
Open	20.20
Previous Close	20.10
Day's Range	20.20 - 20.20
52-Week Range	15.37 - 20.35
Beta	-0.03
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 5, 2026

About MediPal Holdings

MediPal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. The company engages in the manufacture and supply of medical drugs, medical devices, medical supplies, clinical test reagents, and medical equipment and materials; non-life insurance agency business; outsourcing of medical office administration services; research and development of preventive medicine and cutting-edge medical technologies; and construction of a medical materials database. It is also involved in the wholesale of cosmetics, daily ...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1898
• Employees: 13,024
• Stock Exchange: OTCMKTS
• Ticker Symbol: MAHLY

Financial Performance

In fiscal year 2026, MediPal Holdings's revenue was 3.82 trillion, an increase of 3.98% compared to the previous year's 3.67 trillion. Earnings were 42.53 billion, an increase of 5.60%.

Financial numbers in JPY

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 9, 2026

Data Sources Report a data error